Artos

What Artos does

Artos is a Y Combinator-backed, San Francisco-based software company that builds an AI-powered document creation and management platform for life sciences organizations preparing regulatory submissions. Founded in 2023 and operating with a team of 1–10, the company targets medical writing, CMC, regulatory affairs, regulatory intelligence, IT, and engineering functions within large pharmaceutical companies, small and mid-sized pharma, capital-constrained biotechs, and CRO/medical writing firms. The platform covers the full document lifecycle for INDs, NDAs, and BLAs across the CTD pyramid, including Clinical Study Reports, Non-Clinical Overviews, CMC documents, Module 2 Written Summaries, Investigator's Brochures, and Quality Overall Summaries.

The platform's core technology is an agentic modular architecture composed of discrete, reusable agents (data extraction, information retrieval, content reuse, table analysis, summarization, conclusion drafting, QC) orchestrated for each document type rather than relying on generic LLM prompts. Artos combines deterministic software with generative AI for reliability, processes multi-modal inputs including tables, figures, scanned PDFs, and handwritten notes, and embeds purpose-built AI systems co-developed with subject matter experts. Differentiated capabilities include Source Tracer (traceability of every generated section back to original data, validated against tens of thousands of tables), Inconsistency Intelligence (cross-document change-impact tracking), Auditable Automations with GxP validation logic, custom templates, and HL7 FHIR data standards support. Integrations span Veeva RIM, SharePoint, Google Drive, Box, and Microsoft Teams, and the platform is SOC2 Type 2 compliant, GDPR-compliant, and designed for GxP software requirements.

Artos operates a SaaS subscription revenue model with quote-based enterprise pricing for large organizations (typically multi-year contracts) and a self-serve monthly signup tier for smaller buyers. Distribution combines enterprise field sales targeting large pharma, biotech, and CROs — anchored by a 'Book Demo' call-to-action — with content marketing, free eCTD templates, and an active presence at industry events such as DIA, RAPS Convergence, BioTechX USA, AMWA, and JPM Healthcare. The company is led by co-founder and CEO Josh Kim and co-founder Varun Patel, with a team that includes AI governance and adoption specialists. Disclosed funding totals $500,000 from a February 2024 seed round led by Y Combinator with Pioneer Fund participation; no revenue, ARR, or customer count has been publicly disclosed.

Name

Artos

Legal name

Artos

Website

https://www.artosai.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

Artos is an AI-powered document creation and management platform that helps life sciences teams (large pharma, biotech, CROs) draft and manage regulatory submission documents (INDs, NDAs, BLAs, CSRs, CMC) faster, with traceability and GxP compliance.

Ownership category

akta.pro rank

Product category

Regulatory Document Automation Software

NAICS

Software Publishers (513210)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Intelligent Document Processing (IDP) & OCR Automation (HDAEAHAC)

akta.pro secondary industries

Electronic Data Capture (EDC) Platforms (HLACAOAA), AI Integration & Orchestration Platforms (Connectors, Workflow, iPaaS for AI) (HDAEANAI)

Keywords

• Regulatory document automation
• Medical writing software
• AI document drafting
• Clinical study reports
• Regulatory submission software

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. SaaS Subscription: Artos operates as a SaaS platform with subscription-based pricing. The company offers scalable pricing models designed to be cost-effective compared to building AI systems internally. Pricing is positioned as up to 20x cheaper per employee than internal development.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

Artos provides an AI-powered document drafting and management SaaS platform that converts life sciences data and reports into submission-ready regulatory packages for INDs, NDAs, and BLAs. The platform delivers purpose-built generative AI for each document type (Clinical Study Reports, Non-Clinical Overviews, Module 2 summaries, CMC documents, Investigator's Brochures) with full source traceability, multi-modal support for tables and figures, GxP-compliant automations, and integrations with Veeva RIM, SharePoint, Box, and Google Drive.

Product overview

Artos is an AI-powered document creation and management platform for the life sciences industry, consisting of a unified platform with integrated modules. The core platform includes Document Drafting, Source Tracer, Inconsistency Intelligence, Custom Templates, Section Regeneration, Audit Logs, Search, and Automations. These modules work together as an end-to-end suite handling the entire CTD pyramid from raw data to final draft for INDs, NDAs, and BLAs. The platform serves various team functions including Medical Writing, CMC, Regulatory Affairs, Regulatory Intelligence, IT, and Engineering, with solutions optimized for Large Pharma, Medium Pharma, Biotech, and CRO/Medical Writing Firms organizations.

Differentiator

Problem solved

Functional benefit

Products and services

• Artos Platform End-to-end AI-powered SaaS platform for life sciences document creation and management across the entire CTD pyramid, from raw data to final draft for INDs, NDAs, and BLAs. The unified suite delivers Document Drafting, Source Tracer, Inconsistency Intelligence, Custom Templates, Section Regeneration, Audit Logs, Search, and Automations, with integrations to Veeva RIM, SharePoint, Box, and Google Drive, and supports HL7 FHIR standards. Purpose-built AI systems exist for each document type — Clinical Study Reports, Non-Clinical Overviews, Module 2 Written Summaries, CMC documents, Investigator's Brochures, Quality Overall Summaries, Tabulated Summaries, and more. Sold primarily via enterprise subscription with deployment in under 7 days and value realization within 2 weeks, also available via self-serve online signup for smaller organizations. SOC2-compliant, GDPR-compliant, and GxP-ready.

Quantifiable outcome

• Time savings of 50-80% on document drafting and review cycles
• +6 more outcomes

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability10 records

Feature8 records

Partnerships

Four partnerships are on record, tiered core.

• VeevacoreTechnology or IntegrationHigh-fidelity integration with Veeva RIM, the most widely used document management system for regulatory submissions. Allows seamless document management within existing regulatory workflows.
• SharePointcoreTechnology or IntegrationIntegration to read, write, and manage documents from SharePoint accounts directly within the Artos platform.
• Google DrivecoreTechnology or IntegrationSeamless integration allowing users to read, write, and manage documents from Google Drive accounts within Artos.
• BoxcoreTechnology or IntegrationIntegration to sync and manage documents with company Box systems for seamless document management workflows.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Veeva Systems: Veeva is the dominant cloud software provider for life sciences, including the Veeva Vault RIM platform for regulatory information management. Artos integrates with Veeva RIM and competes for the same regulated-document workflows, but Veeva offers a far broader portfolio across clinical, regulatory, quality, and commercial.
• IQVIA: IQVIA is a global CRO and life sciences technology vendor offering regulatory, clinical, and AI-driven analytics solutions. It competes for the same pharmaceutical medical writing and regulatory operations budgets that Artos targets, particularly with its AI-augmented offerings across the drug development lifecycle.
• Medidata (Dassault Systèmes): Medidata provides clinical trial technology including EDC and CTMS as part of the Dassault Systèmes 3DEXPERIENCE platform. It serves overlapping pharma clinical and regulatory workflows and has begun embedding AI features that could encroach on Artos's authoring wedge.

Direct peers

• Certara: Certara provides regulatory and scientific software and services including regulatory writing, submission management, and biosimulation for pharma. Its D360 and submission management tools directly overlap with Artos's regulatory document drafting and CTD-authoring focus, serving the same medical writing teams.
• ArisGlobal: ArisGlobal offers LifeSphere Regulatory and Safety platforms for life sciences, including document and submission management. It targets the same pharma regulatory operations buyers as Artos and increasingly integrates AI features into its regulatory product suite.
• Kneat Solutions: Kneat provides digital validation and regulated document lifecycle management software for life sciences, including electronic validation and document authoring workflows. It addresses similar GxP-compliant authoring and review use cases in pharma and biotech.
• Yseop: Yseop is an AI-driven natural language generation platform with deep presence in life sciences regulatory and medical writing automation. It is the most direct AI-native competitor to Artos in automating clinical study reports and regulatory submission narratives.

Emerging players

• Saama Technologies: Saama offers AI-driven clinical development and regulatory analytics for life sciences, including clinical data management and submission insights. It overlaps with Artos in using AI to accelerate regulatory and clinical workflows for pharma and biotech.
• ComplianceQuest: ComplianceQuest provides AI-enabled quality, document, and regulatory management software on Salesforce for life sciences manufacturers. It targets overlapping GxP-regulated document and change management use cases but with a broader QMS focus rather than authoring-specific AI.

Others

• OpenAI (ChatGPT Enterprise): OpenAI's ChatGPT Enterprise and API are increasingly used by pharma medical writing teams for general-purpose drafting assistance. While not life sciences-specific, large pharma IT teams building internal AI stacks on OpenAI represent a credible alternative deployment path versus buying Artos.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Artos_AI
• LinkedInlinkedin.com/company/artosai

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Artos